Jinchen Hu

Jinchen Hu


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2025 in Digestive Diseases and Sciences
Verified
Journal Article
Open access
PDF file
ZYZhensong Yang
Zhensong Yang
BYBin Yu
Bin Yu
JHJinchen Hu
Jinchen Hu
LJLixin Jiang
Lixin Jiang
MJMi Jian
Mi Jian
Background Leucine-rich repeat containing 25 (LRRC25) is distinguishingly expressed in different tumor types, but the relationship with immune cell infiltration in gastric cancer stills unclear. We analyzed LRRC25 expression using pan-cancer data from The Cancer Genome Atlas and gene data from Gene Expression Omnibus. The clinical significance was further evaluated using gastric cancer tissues derived from clinical trials (no. NCT04208347). Method Through bioinformatics analysis of TCGA database and the UCSC Xena database, we found the correlation between LRRC15, gastric cancer, and immune cell infiltration. Further, multiplex immunohistochemistry/immunofluorescence (mIHC/IF), tissue microarray, and image acquisition and quantitative analysis confirmed our theory. Results It was discovered that LRRC25 was highly expressed in gastric cancer. Further analysis revealed that the expression of LRRC25 associated with gene sets implicated in immunity, including those in innate immunity, adaptive immunity, and chemokine signaling pathways. The result of (mIHC/IF) suggests a negative relevance between LRRC25 and response of anti-PD-1 treatment and reveals a trend of consistent change on LRRC25 + cells and CD16 expression. We also discovered that LRRC25 expression significantly associated with immune cell infiltration level. In particular, there is a relationship between LRRC25 and the phenotype and function of NK cells. Conclusion High LRRC25 expression contributes to immunosuppressive microenvironment by influencing chemokine axis in gastric cancer. LRRC25 may serve as a clinically useful biomarker for predicting neoadjuvant immunotherapeutic response in patients with gastric cancer. LRRC25 can affect the phenotype and function of NK cells.

1 January 2019
Verified
Journal Article
Closed access
GYGuohua Yu
Guohua Yu
JXJianfeng Xu
Jianfeng Xu
LJLei Jiang
Lei Jiang
LCLi Cai
Li Cai
YZYaniv Zohar
Yaniv Zohar
JHJinchen Hu
Jinchen Hu

1 January 2020
Verified
Closed access
LCLi Cai
Li Cai
TWTing Wang
Ting Wang
LJLei Jiang
Lei Jiang
PYPing Yang
Ping Yang
JHJinchen Hu
Jinchen Hu
JJJing Jiang
Jing Jiang

12 November 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RCRuyue Chen
Ruyue Chen
ZYZengwu Yao
Zengwu Yao
LJLixin Jiang
Lixin Jiang
JHJinchen Hu
Jinchen Hu
Despite the persistent high incidence and mortality rates of gastric cancer, limited progress has been made in improving prognosis.cancer-associated fibroblasts (CAFs) hold promise as novel biomarkers, yet their specific roles and mechanisms in gastric cancer remain enigmatic. We utilized the TCGA-STAD dataset for model training and the GSE84433 dataset for validation to explore potential associations between cancer-associated fibroblasts (CAFs) and clinical outcomes in gastric cancer. Through consensus clustering, differential expression analysis, enrichment analysis, and immune infiltration assessment, Kaplan–Meier (KM) survival analysis, and TIMER database exploration, we examined the prognostic significance and underlying biological mechanisms of CAF-related genes in gastric cancer. A CAF risk model (CAF-RM) was developed to assess the correlation between risk scores and survival, drug sensitivity, and immune infiltration. The model was further validated through immunohistochemical (IHC) and immunofluorescence (IF) staining. Utilizing data from 42 CAF-related genes, consensus clustering identified two distinct patient subgroups, C1 and C2, with significant differences in survival, immune scores, and immune cell infiltration. A Cox-Lasso regression-derived CAF-RM accurately discriminated high-risk from low-risk gastric cancer patients, consistent with validation cohort results, IHC and IF staining. These findings suggest that CAFs play a role in the tumor immune microenvironment of gastric cancer and highlight the efficacy of CAF-RM in prognosis prediction. CAF subtypes associate with immune tumor microenvironment alterations in gastric cancer. The validated CAF risk model predicts patient survival, immune infiltration, and drug sensitivity, enhancing understanding of CAFs and guiding gastric cancer therapy.

22 January 2025 in Discover Oncology
Verified
Journal Article
Open access
PDF file
RCRuyue Chen
Ruyue Chen
ZYZengwu Yao
Zengwu Yao
LJLixin Jiang
Lixin Jiang
JHJinchen Hu
Jinchen Hu
Background Gastric cancer (GC) remains a significant health burden, calling for the discovery of novel biomarkers. Golgi apparatus, a crucial cellular organelle involved in tumorigenesis, remains underexplored in GC research. A comprehensive understanding of its role and associated mechanisms is urgently needed. Materials and methods Utilizing the TCGA-STAD dataset as the training cohort and GSE84433 as the validation cohort, we explored potential associations between Golgi apparatus-related genes (GARG) and GC clinical risk. We aimed to decipher the prognostic significance and underlying biological mechanisms of these genes via consistent clustering, differential expression analysis, enrichment analyses, and immune infiltration profiling. To assess the relationship between risk stratification and survival outcomes, drug sensitivity, and immune infiltration, we developed the Golgi Apparatus-Related Risk Signature (GARRS). The reliability of GARRS was further corroborated using immunohistochemical staining. Results Consensus clustering based on 17 GARG identified two patient subgroups, C1 and C2, exhibiting differential survival, immune scores, and immune cell infiltration. We developed a GARRS using Cox-Lasso regression analysis, accurately stratifying patients into high- and low-risk groups. GARRS’ validity was confirmed in the validation set and immunohistochemical staining. Our findings underline the Golgi apparatus' significance in the GC immune microenvironment and GARRS' utility in predicting GC survival outcomes. Conclusion This study underscores the association between Golgi apparatus subtypes and GC immunotumor microenvironment. GARRS, validated for its prognostic, immune infiltration, and drug sensitivity predictive abilities, offers new insights into gastric cancer treatment strategies.

17 August 2023 in International Journal of Surgery
Verified
Journal Article
Open access
ZYZengwu Yao
Zengwu Yao
JHJinchen Hu
Jinchen Hu
LJLixin Jiang
Lixin Jiang
An abstract is unavailable. This article is available as a PDF only.